BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE

BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE
$2.9323per EA
Discontinued

Strength

140; 125; 125 mg/1; mg/1; mg/1

Manufacturer

H2-Pharma LLC

NDC

61269038512

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA050786

On Market Since

7/31/2023

Pharmacological Classes

Price History

1W

0.0%

1M

-7.0%

3M

-7.9%

6M

-11.8%

1Y

-26.9%

3Y

N/A

5Y

N/A

All

-34.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.